Erik Magnus Berntsen
Overview
Explore the profile of Erik Magnus Berntsen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
391
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vindstad B, Skjulsvik A, Pedersen L, Berntsen E, Solheim O, Ingebrigtsen T, et al.
Cancers (Basel)
. 2024 Jul;
16(14).
PMID: 39061219
Background: Gliomas have a heterogeneous nature, and identifying the most aggressive parts of the tumor and defining tumor borders are important for histomolecular diagnosis, surgical resection, and radiation therapy planning....
2.
Husby T, Johannessen K, Berntsen E, Johansen H, Giskeodegard G, Karlberg A, et al.
EJNMMI Rep
. 2024 May;
8(1):2.
PMID: 38748286
Background: This PET/MRI study compared contrast-enhanced MRI, F-FACBC-, and F-FDG-PET in the detection of primary central nervous system lymphomas (PCNSL) in patients before and after high-dose methotrexate chemotherapy. Three immunocompetent...
3.
Stige K, Kverneng S, Sharma S, Skeie G, Sheard E, Sognen M, et al.
Prog Neurobiol
. 2024 Apr;
236:102603.
PMID: 38604582
The STRAT-PARK initiative aims to provide a platform for stratifying Parkinson's disease (PD) into biological subtypes, using a bottom-up, multidisciplinary biomarker-based and data-driven approach. PD is a heterogeneous entity, exhibiting...
4.
Karlberg A, Pedersen L, Vindstad B, Skjulsvik A, Johansen H, Solheim O, et al.
Eur J Nucl Med Mol Imaging
. 2023 Sep;
51(2):496-509.
PMID: 37776502
Purpose: The primary aim was to evaluate whether anti-3-[F]FACBC PET combined with conventional MRI correlated better with histomolecular diagnosis (reference standard) than MRI alone in glioma diagnostics. The ability of...
5.
Oen S, Johannessen K, Pedersen L, Berntsen E, Totland J, Johansen H, et al.
Clin Nucl Med
. 2022 Oct;
47(12):1030-1039.
PMID: 36241129
Purpose: The study aims to evaluate whether combined 18 F-FACBC PET/MRI could provide additional diagnostic information compared with MRI alone in brain metastases. Patients And Methods: Eighteen patients with newly...
6.
Unsgard R, Doan T, Nordlid K, Kvistad K, Goa P, Berntsen E
Neuroradiology
. 2022 Jun;
64(12):2217-2226.
PMID: 35754063
Purpose: To assess the ability of 7 T MRI to detect hippocampal DWI lesions in the acute phase of TGA compared to 1.5 T/3 T MRI. Methods: Patients with a...
7.
Johannessen K, Berntsen E, Johansen H, Solheim T, Karlberg A, Eikenes L
Eur J Hybrid Imaging
. 2021 Jun;
5(1):7.
PMID: 34181107
Background: Patients with metastatic cancer to the brain have a poor prognosis. In clinical practice, MRI is used to delineate, diagnose and plan treatment of brain metastases. However, MRI alone...
8.
Berntsen E, Haukedal M, Haberg A
Pituitary
. 2021 May;
24(5):737-745.
PMID: 33973151
Purpose: The main aim of this study was to provide normative data for pituitary height and volume in persons between 50 and 66 years in the general population. The secondary...
9.
Fyllingen E, Bo L, Reinertsen I, Jakola A, Sagberg L, Berntsen E, et al.
Acta Neurochir (Wien)
. 2021 Mar;
163(7):1895-1905.
PMID: 33742279
Purpose: Previous studies on the effect of tumor location on overall survival in glioblastoma have found conflicting results. Based on statistical maps, we sought to explore the effect of tumor...
10.
Mikkelsen V, Dai H, Stensjoen A, Berntsen E, Salvesen O, Solheim O, et al.
J Neuropathol Exp Neurol
. 2020 Jul;
79(8):855-862.
PMID: 32688383
O6-methylguanine DNA methyltransferase (MGMT) promoter methylation is an important favorable predictive marker in patients with glioblastoma (GBM). We hypothesized that MGMT status could be a surrogate marker of pretreatment tumor...